|Title||Small Animal Models for Human Immunodeficiency Virus (HIV), Hepatitis B, and Tuberculosis: Proceedings of an NIAID Workshop.|
|Publication Type||Journal Article|
|Year of Publication||2019|
|Authors||Akkina, R, Barber, DL, Bility, MT, Bissig, K-D, Burwitz, BJ, Eichelberg, K, Endsley, JJ, J Garcia, V, Hafner, R, Karakousis, PC, Korba, BE, Koshy, R, Lambros, C, Menne, S, Nuermberger, EL, Ploss, A, Podell, BK, Poluektova, LY, Sanders-Beer, BE, Subbian, S, Wahl, A|
|Journal||Curr HIV Res|
|Date Published||2019 Dec 22|
The main advantage of animal models of infectious diseases over in vitro studies is the gain in understanding of the complex dynamics between the immune system and the pathogen. While small animal models have practical advantages over large animal models, it is crucial to be aware of their limitations. Although the small animal model at least needs to be susceptible to the pathogen under study to obtain meaningful data, key elements of pathogenesis should also be reflected when compared to humans. Well-designed small animal models for HIV, hepatitis viruses, and tuberculosis require additionally a thorough understanding of similarities and differences in the immune responses between humans and small animals and should incorporate that knowledge into the goals of the study. To discuss these considerations, the NIAID hosted a workshop on 'Small Animal Models for HIV, Hepatitis B, and Tuberculosis' on May 30, 2019. Hightlights of the workshop are outlined below.
|Alternate Journal||Curr. HIV Res.|